Controlled Fluid Resuscitation in Sepsis
1 other identifier
interventional
550
0 countries
N/A
Brief Summary
To evaluate two different strategy of fluid resuscitation in sepsis patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable sepsis
Started Jan 2018
Longer than P75 for not_applicable sepsis
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2017
CompletedFirst Posted
Study publicly available on registry
July 12, 2017
CompletedStudy Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedJuly 12, 2017
July 1, 2017
3 years
July 7, 2017
July 8, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality
Mortality
the 28th day from enrolled
Secondary Outcomes (1)
Mortality
the 60th day from enrolled
Study Arms (2)
EGDT Group
OTHEREarly Goal Directed Therapy :30ml/kg in the first bolus to have a CVP(central venous pressure) 8-12 mmHg and MAP(mean artery pressure ) 65-85 mm Hg,and urine output ≥0.5 ml/kg/h, ScvO2 ≤70%;If not, use noradrenaline,red blood cell transfusion if necessary.
Ruijin Group
OTHERRuijin Strategy therapy:10\~5ml/kg/h,crystalloid vs colloid 2:1 resuscitation;using noradrenaline at the same time;red blood cell transfusion if necessary. target: fulfillment of two or more of four criteria:1. HR(heart rate) \<120 beats/min, 2.MAP 65-85 mm Hg, 3. urine output ≥1 ml/kg /h 4. HCT(hematocrit) 25%\~35%.
Interventions
EGDT therapy :30ml/kg in the first bolus to have a CVP 8-12 mmHg and MAP 65-85 mm Hg,and urine output ≥0.5 ml/kg/h, ScvO2 ≤70%;If not, use noradrenine,red blood cell transfusion if necessary.
Ruijin Strategy:10\~5ml/kg/h,crystalloid vs colloid 2:1 resuscitation;using noradrenaline at the same time;red blood cell transfusion if necessary. target: fulfillment of two or more of four criteria:1. HR \<120 beats/min, 2.MAP 65-85 mm Hg, 3. urine output ≥1 ml/kg /h 4. HCT 25%\~35%.
Eligibility Criteria
You may qualify if:
- sepsis patients in accordance with the Sepsis 3.0 definition(SOFA increase ≥2 compared to the baseline,due to infection )
- the first blood lactate in our hospital is ≥ 4mmol/L or MAP\<90mmHg after 20ml/kg fluid bolus
- the shock is diagnosed within 24hrs after onset
You may not qualify if:
- \- 1.\<18 years old
- Pregnancy
- with co-morbidity such as AE-COPD, stroke, seizure, lung edema, acute coronary syndrome
- with contra-indication of CVC(central venous catheter) placement
- trauma or major burn
- poisoning
- any cancer receiving chemotherapy
- immunosuppression (for organ transplantation or disease of immune system)
- acute pancreatitis
- relapse sepsis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
- RenJi Hospitalcollaborator
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicinecollaborator
Related Publications (4)
Mao EQ, Tang YQ, Fei J, Qin S, Wu J, Li L, Min D, Zhang SD. Fluid therapy for severe acute pancreatitis in acute response stage. Chin Med J (Engl). 2009 Jan 20;122(2):169-73.
PMID: 19187641BACKGROUNDARISE Investigators; ANZICS Clinical Trials Group; Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams P. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014 Oct 16;371(16):1496-506. doi: 10.1056/NEJMoa1404380. Epub 2014 Oct 1.
PMID: 25272316BACKGROUNDNational Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network; Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006 Jun 15;354(24):2564-75. doi: 10.1056/NEJMoa062200. Epub 2006 May 21.
PMID: 16714767BACKGROUNDSinger M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
PMID: 26903338BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Zhen Er Chen
Shanghai Jiao Tong University School of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 7, 2017
First Posted
July 12, 2017
Study Start
January 1, 2018
Primary Completion
December 31, 2020
Study Completion
June 30, 2021
Last Updated
July 12, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share